The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

The Clinical Effectiveness of Frequently Used Herbal Medicines for Cerebrovascular Disease: A Retrospective Study

뇌혈관질환에 대한 다빈도 처방 한약의 임상적 유효성 : 후향적 연구

  • Seo, Hee-jeong (Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University) ;
  • Shim, So-hyun (Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University) ;
  • Kwon, Jung-nam (Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University) ;
  • Hong, Jin-woo (Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University) ;
  • Lee, In (Dept. of Korean Internal Medicine, Korean Medicine Hospital of Pusan National University)
  • 서희정 (부산대학교 한방병원 내과학교실) ;
  • 심소현 (부산대학교 한방병원 내과학교실) ;
  • 권정남 (부산대학교 한방병원 내과학교실) ;
  • 홍진우 (부산대학교 한방병원 내과학교실) ;
  • 이인 (부산대학교 한방병원 내과학교실)
  • Received : 2019.08.30
  • Accepted : 2019.11.07
  • Published : 2019.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: With the aging of the population, the incidence of a variety of diseases is increasing. Cerebrovascular disease is a major cause of mortality worldwide and therefore requires timely treatment and management. We aimed to evaluate the clinical effectiveness of herbal medicines in treating cerebrovascular disease by screening the most frequently prescribed herbal medicines and analyzing the clinical data of patients with cerebrovascular disease taking these medicines. Methods: In this retrospective study, we analyzed the electronic medical records of patients with cerebrovascular disease who received herbal medication at the Pusan National University Korean Medical Hospital from 10 March 2010 to 31 March 2017. The inclusion criteria were as follows: diagnosis of cerebrovascular disease, use of frequently prescribed herbal medicines, available records of laboratory tests and functional evaluation that was conducted within two weeks before and after admission and discharge, and herbal medicine usage exceeding half the period of hospitalization. Results: Of the total patients with cerebrovascular disease, the number of patients analyzed in this study was 49. There were some changes in the various variables examined after frequently used herbal medicines had been taken, such as complete blood count, liver function test, lipid test, and functional evaluation. No serious adverse events related to herbal medicine were found in this study. Conclusions: We concluded that herbal medicines frequently used for cerebrovascular disease may have some clinical effectiveness. However, because of the retrospective nature of this study and only one hospital involved, the generalizability of our findings is limited.

Keywords

References

  1. Statistics-Korea: Population projections for Korea : 2017-2067. In: http://kostat.go.kr/portal/korea/kor_nw/1/1/index.board?bmode=read&aSeq=373873. Statistics Korea; 2019
  2. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet 2014;383(9913):245-55. https://doi.org/10.1016/S0140-6736(13)61953-4
  3. Clinical research center for stroke. Korean Clinical Practice Guidelines for Stroke (revised edition). 2013 Feb; [cited 2016 Dec 27]. Available at: URL: http://www.stroke-crc.or.kr/%EB %87%8C%EC%A1%B8%EC%A4%91%EC%A7%84%EB%A3%8C%EC%A7%80%EC%B9%A8%2020130322.pdf
  4. Ministry of Health and Welfare. Survey on Korean medicine use and consumption 2014. 2011 Dec 7; [cited 2016 Dec 27]. Available at: URL:http://www.prism.go.kr/homepage/theme/retrieveThemeDetail.do;jsessionid=8C0E78708F3DAB1DD75E9C6186430BE8.node02?cond_research_name=&cond_organ_id=&cond_research_year_start=&cond_research_year_end=&cond_brm_super_id=NB000120061201100060495&research_id=1351000-201100127&pageIndex=6&leftMenuLevel=110.
  5. Kim MK, Han CH. E-mail survey on the current status of clinical practice and activation measures for Korean medicine in stroke care. J Korean Med 2017;38(3):143-59. https://doi.org/10.13048/jkm.17032
  6. WHO. Global Health Estimates 2016 : CAUSE-SPECIFIC MORTALITY, 2000-2016. 2017.
  7. Statistics-Korea: Cause of death statistics : 2017. In : http://www.kostat.go.kr/portal/korea/kor_nw/1/6/2/index.board?bmode=read&bSeq=&aSeq=370710&pageNo=1&rowNum=10&navCount=10&currPg=&searchInfo=&sTarget=title&sTxt=. Statistics Korea; 2018.
  8. Lee SW, Kim HC, Lee HS, Suh I. Thirty-Year Trends in Mortality from Cerebrovascular Diseases in Korea. Korean Circ J 2016;46(4):507-14. https://doi.org/10.4070/kcj.2016.46.4.507
  9. Korea Centers for Disease Control and Prevention. A study on Measuring the Economic Burden of Cardio-Cerebrovascular Diseases in Korea. Korea University 2010.
  10. 韓東錫. 東醫壽世保元註釋. Seoul: 杏林出版社;1967, p. 300-45.
  11. Han BS, Bae YC, Song SY, Park HS, Lee JH, Kim KY. Antioxidant effects and its mechanism of Cheongsi-myeonjatang in Sasang Constitutional Medicine. J of Sasang Constitutional Medicine 2004;16(1):130-47.
  12. Jung DY, Ha Hk, Lee HY, Lee JA, Lee NH, Lee JK, et al, Stimulation of the Immune Response by Herbal Formulas for Taeeumin. J of Sasang Constitutional Medicine 2010;22(3):141-51.
  13. Park SC. Effects CheongSimYeonJaTang(CSYJT) on control of immune-function in highly purified mouse B cells and Mast cell. J Sasang Constitut Med 2003;15(2):166-79.
  14. Lee JA, Ha Hk, Lee HY, Jung DY, Lee JK, Huang DS, et al. Anti-inflammatory Activities of Herbal Formulas for Sasang Constitutional Medicine. J of Sasang Constitutional Medicine 2010;22(4):56-64.
  15. Seo CS, Jeong SJ, Kim JH, Yoo SR, Shin HK. Simultaneous Analysis and Anti-obesity Effect of Taeeumin Cheongsimyeonja-tang. J Sasang Constitut Med 2013;25(1):51-61. https://doi.org/10.7730/JSCM.2013.25.1.51
  16. Yoon YS, Keum SO, Lee SW, Kim IH, Lee HI, Song YS. Effects of Cheongshimyeonja-tang on Body Weight and Serum Lipid Levels in High Fat Diet Induced Obese Mice. Herbal Formula Science 2014;22(1):123-39. https://doi.org/10.14374/HFS.2014.22.1.123
  17. Han BS, Ryu DG, Lee SW, Kim KO. Effects of the Chungsimyonjatang water Extract on the Rat Myocardial Cells in Cultures. J Sasang Constitut Med 2001;13(1):70-8.
  18. Yoon HD, Shin OC, Shin YJ, Kim SM. Effect of Chungsimyeonjatang on Myocardiac Cell Injury in Mouse Myoblast C2C12 Cells. J Orient Int Korean Med 2007;28(2):333-45.
  19. Park JH, Kim KY. Effect of Taeumin Chungsimyoinjatang Extract on Blood Pressure and Regional Cerebral Blood Flow in Rats. J Sasang Constitut Med 2000;12(1):216-27.
  20. Kim MW. The Cure Effect of Cheongsimyeonjatang on Atopic Dermatitis by Regulation of Th2 Cell Differentiation and Anti-Inflammatory Mechanism. Dongguk university Doctor's degree 2006.
  21. Kim SW. Effect of Yuldahansotang and Chung -simyeonjatang on the Hepatic Injury. Woosuk University Master's degree 2001.
  22. Ha JH. Comparative Efficacy Study of Hyeong banggiwhang-tang, Cheongsimyeonja-tang and Hyangsayangyi-tang on the 5/6 Nephrectomy induced Chronic Renal Failure Rats. Daegu Haany University Doctor's degree 2013.
  23. Kim YJ, Kim TW, Seo CS, Park SR, Ha Hk, Shin HK, et al. Quatification of Flavonoid Contents in Chungsimyeonja-tang, a Multi-Herbal Decoction, and Its Protective Effect against Cisplatin-induced Nephrotoxicity. Natural Product Sciences 2014;20(4):251-7.
  24. 許浚. 東醫寶鑑. Seoul: 南山堂; 1983, p. 366.
  25. 李梴. 醫學入門. Seoul: 翰成社; 1980, p. 525.
  26. 尹吉榮. 東醫臨床方劑學. Seoul: 明寶出版社; 1985, p. 99.
  27. 成都中醫學院方劑敎硏組. 中醫治法學方劑. 北京: 人民衛生出版社; 1985, p. 208-12.
  28. Shin WT, Heo JE, Kim TH, Hong SH, Kwon OS, Kim KT, Hong SH. Clinical Effect of Dodam-tang on Hyperlipidemia Patients. J Int Korean Med 2007;fal:113-8.
  29. Kim YD, Moon BS, Park YS, Kim SG. Effects of Dodamtang(導痰湯) on the Hyperlipidemia and Intravascular Coagulation Induced Rabbits. The Journal of Wonkang Oriental Medicine 1994;4(1):85-128.
  30. Choi JH, Jeong HW. Effects of Dodamtang and Its Gamypang on the Regional Cerebral Blood Flow and Blood Pressure in Rats. J Physiol & Pathol Korean 2000;14(1):99-106.
  31. Nationwide professors of Herbal formula study co-edit. The herbal formula study Seoul: Yunglim publisher; 2008, p. 410-3.
  32. Wang CI. EuiLimGaeChak iksan: Wonhakkyo; 1998, p. 89-96, 168.
  33. Lee WC, Kim JH. Oriental treatment of neurological diseases Seoul: Jeongdam book publishing; 2005, p. 433.
  34. 陈桂铭. 补肾益脑汤治疗老年性痴呆的体会. Doctor's degree 1992.
  35. 王文超. 补肾益脑汤治疗血管性痴呆床硏究.. Doctor's degree 2012.
  36. 李正树, 彭华, 杨传东, 张晓勤. 补肾益脑汤治疗老年性痴呆23例. 吉林中医药 1995;5:6-7.
  37. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27(3):373-80.
  38. Wolf PA, D'Agostino RB, O'Neal MA, Sytkowski P, Kase CS, Belanger AJ, et al. Secular trends in stroke incidence and mortality. The Framingham Study. Stroke 1992;23(11):1551-5. https://doi.org/10.1161/01.str.23.11.1551
  39. American Heart Association, Heart Disease and Stroke Statistics-2004 Update. Dallas, Tex American Heart Association. 2003.
  40. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360(9349):1903-13. https://doi.org/10.1016/S0140-6736(02)11911-8
  41. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association. Stroke 2006;37(6):1583-633. https://doi.org/10.1161/01.str.0000223048.70103.f1
  42. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis. Stroke 2004;35(12):2902-9. https://doi.org/10.1161/01.str.0000147965.52712.fa
  43. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22(8):983-8. https://doi.org/10.1161/01.STR.22.8.983
  44. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376(9735):112-23. https://doi.org/10.1016/S0140-6736(10)60834-3
  45. Brass LM, Isaacsohn JL, Merikangas KR, Robinette CD. A study of twins and stroke. Stroke 1992;23(2):221-3. https://doi.org/10.1161/01.STR.23.2.221
  46. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989;298(6676):789-94. https://doi.org/10.1136/bmj.298.6676.789
  47. Robbins AS, Manson JE, Lee IM, Satterfield S, Hennekens CH. Cigarette smoking and stroke in a cohort of U.S. Male physicians. Ann Intern Med 1994;120(6):458-62. https://doi.org/10.7326/0003-4819-120-6-199403150-00002
  48. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003;289(5):579-88. https://doi.org/10.1001/jama.289.5.579
  49. Barlas RS, Honney K, Loke YK, McCall SJ, Bettencourt-Silva JH, Clark AB, et al. Impact of hemoglobin levels and anemia on mortality in acute stroke: analysis of UK regional registry data, systematic review, and meta-analysis. J Am Heart Assoc 2016;5(8):e003019. https://doi.org/10.1161/JAHA.115.003019
  50. Seo CS, Jeong SJ, Kim JH, Yoo SR, Shin Hyeun-Kyoo. Simultaneous Analysis and Anti-obesity Effect of Taeeumin Cheongsimyeonja-tang. J Sasang Constitut Med 2013;25(1):51-61. https://doi.org/10.7730/JSCM.2013.25.1.51
  51. Yoon YS, Keum SO, Lee SW, Kim IH, Lee HI, Song YS. Effects of Cheongshimyeonja-tang on Body Weight and Serum Lipid Levels in High Fat Diet Induced Obese Mice. Herbal Formula Science 2014;22(1):123-39. https://doi.org/10.14374/HFS.2014.22.1.123
  52. Ju LS, Ahn TW. Study of Cheongsimyeonja-tang that get weight, hematology, biochemistry change by Wistar rat's aging. J Daejeon Orient Med 2004;13(2):337-45.